Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06646419 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle

Study acronym: BRIDGE-COPD
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Trial completed Primary and study completion dates changed from estimate of Aug 31, 2026 to Sep 21, 2026 · Eligibility criteria expanded, about 11 words Show 2 more changesShow less
    • Primary and study completion dates changed from estimate of Aug 31, 2026 to Sep 21, 2026
    • Eligibility criteria expanded, about 11 words
  3. 3 versions Re-verified since Feb 18, 2026, no change to tracked fieldsv12-v14
  4. Trial status: Recruiting to Active, Not Recruiting Site details revised at 37 of 37 sitesv11 Show 1 more changeShow less
    • Site details revised at 37 of 37 sites
  5. Site details revised at 5 of 37 sitesv10
Show 8 earlier versionsHide 8 earlier versions
  1. Site details revised at 8 of 37 sitesv9
  2. Site details revised at 3 of 37 sitesv8
  3. Site details revised at 7 of 37 sitesv7
  4. Site details revised at 4 of 37 sitesv6
  5. Site details revised at 7 of 37 sitesv5
  6. Site details revised at 3 of 37 sitesv4
  7. Study sites: 26 to 37v3
  8. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 26 · Start date changed from estimate of Nov 30, 2024 to Nov 13, 2024v2 Show 2 more changesShow less
    • Study sites: 0 to 26
    • Start date changed from estimate of Nov 30, 2024 to Nov 13, 2024
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
727 trials monitored
See 61 trials at risk
COPD
1,068 trials monitored
See 31 trials at risk
This is a cluster randomized interventional study. Intervention is implemented at a hospital level and will change overall daily practice. 36 county level hospitals are r an domized to the intervention group or control group at the ratio of 2:1 . Total subjects is 1368 and a size of 38 per hospital .
Trial Details
NCT Number NCT06646419
Lead Sponsor AstraZeneca
Conditions COPD
Enrollment 1,368 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov